Is Neko Health’s body scan worth it? Spotify billionaire’s startup has come to America

Daniel Ek’s Neko Health has secured $700 million to build a business around whole-body scanning, marking a significant bet on consumer-oriented preventative healthcare. The startup is expanding into the U.S. market amid growing attention to technologies that promise routine, noninvasive assessments of people’s health.

Neko is not alone: the topic has drawn activity from other well-funded teams. Midjourney is reported to be working on its own body scanner, and Function Health has raised capital to develop a preventative-health platform. Together, these efforts indicate a broader trend of companies placing early-stage hardware and continuous-monitoring services at the center of their roadmaps.

On TechCrunch’s Equity podcast, host Dominic-Madori Davis spoke with Farooq Abbasi of Preface Ventures, an investor in Neko Health, about how Neko compares with other consumer-health startups and what milestones are needed for body scanning to become part of mainstream healthcare. The conversation focused on commercial positioning and the practical steps required for such technologies to integrate into existing clinical workflows.

The episode and reporting highlight both investor enthusiasm and the unresolved challenge of moving from consumer-facing scans to clinically accepted tools. As multiple entrants pursue similar strategies, the degree to which these devices gain regulatory, clinical, and payer acceptance will be central to determining their long-term role in healthcare.